375 related articles for article (PubMed ID: 29652813)
1. The Microenvironment in Epstein-Barr Virus-Associated Malignancies.
Tan GW; Visser L; Tan LP; van den Berg A; Diepstra A
Pathogens; 2018 Apr; 7(2):. PubMed ID: 29652813
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.
Zheng X; Huang Y; Li K; Luo R; Cai M; Yun J
Viruses; 2022 May; 14(5):. PubMed ID: 35632758
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus-Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies.
Bauer M; Jasinski-Bergner S; Mandelboim O; Wickenhauser C; Seliger B
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680337
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus.
Paludan C; Münz C
Curr Mol Med; 2003 Jun; 3(4):341-7. PubMed ID: 12776989
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus infection and nasopharyngeal carcinoma.
Tsao SW; Tsang CM; Lo KW
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-encoded microRNAs as regulators in host immune responses.
Wang M; Yu F; Wu W; Wang Y; Ding H; Qian L
Int J Biol Sci; 2018; 14(5):565-576. PubMed ID: 29805308
[TBL] [Abstract][Full Text] [Related]
7. Immune Evasion by Epstein-Barr Virus.
Ressing ME; van Gent M; Gram AM; Hooykaas MJ; Piersma SJ; Wiertz EJ
Curr Top Microbiol Immunol; 2015; 391():355-81. PubMed ID: 26428381
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection: basis of malignancy and potential for therapy.
Murray PG; Young LS
Expert Rev Mol Med; 2001 Nov; 3(28):1-20. PubMed ID: 14585152
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated lymphoproliferative disorders.
Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma.
Zhang J; Huang T; Zhou Y; Cheng ASL; Yu J; To KF; Kang W
J Cell Mol Med; 2018 Jan; 22(1):38-45. PubMed ID: 28990284
[TBL] [Abstract][Full Text] [Related]
11. Lytic Induction Therapy against Epstein-Barr Virus-Associated Malignancies: Past, Present, and Future.
Yiu SPT; Dorothea M; Hui KF; Chiang AKS
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32748879
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment and RIG-I signaling molecules in Epstein Barr virus-positive and -negative classical Hodgkin lymphoma of the elderly.
Satoh T; Wada R; Yajima N; Imaizumi T; Yagihashi S
J Clin Exp Hematop; 2014; 54(1):75-84. PubMed ID: 24942949
[TBL] [Abstract][Full Text] [Related]
13. Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma.
Huang SCM; Tsao SW; Tsang CM
Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29617291
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines.
Grossman L; Chang C; Dai J; Nikitin PA; Jima DD; Dave SS; Luftig MA
mSphere; 2017; 2(6):. PubMed ID: 29202043
[TBL] [Abstract][Full Text] [Related]
16. Epstein-barr virus vaccines.
Cohen JI
Clin Transl Immunology; 2015 Jan; 4(1):e32. PubMed ID: 25671130
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
Hui KF; Tam KP; Chiang AKS
Viruses; 2017 Nov; 9(11):. PubMed ID: 29160853
[TBL] [Abstract][Full Text] [Related]
18. Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer.
Atri-Schuller A; Abushukair H; Cavalcante L; Hentzen S; Saeed A; Saeed A
Curr Issues Mol Biol; 2022 Nov; 44(11):5756-5767. PubMed ID: 36421674
[TBL] [Abstract][Full Text] [Related]
19. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection.
Zhang B; Zong Y; He J; Zhong B; Lin S
Chin Med J (Engl); 2003 Jun; 116(6):913-7. PubMed ID: 12877806
[TBL] [Abstract][Full Text] [Related]
20. Relationship between PPP1R15A gene polymorphism (rs611251) and Epstein-Barr virus-associated tumors.
Song Y; Liu S; Zhao Z; Zhang Y; Yang Y; Luo B
Acta Virol; 2017; 61(4):445-452. PubMed ID: 29186961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
